Previous 10 | Next 10 |
Image source: The Motley Fool. Amphastar Pharmaceuticals Inc (NASDAQ: AMPH) Q2 2020 Earnings Call Aug 6, 2020 , 5:00 p.m. ET Operator Continue reading
Amphastar Pharmaceuticals (NASDAQ: AMPH ) : Q2 Non-GAAP EPS of $0.16 beats by $0.02 ; GAAP EPS of $0.00. More news on: Amphastar Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...
RANCHO CUCAMONGA, Calif., Aug. 06, 2020 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) (“Amphastar” or the “Company”) today reported results for the three months ended June 30, 2020. Second Quarter Highlights Net revenues of $85.8 mill...
RANCHO CUCAMONGA, Calif., July 30, 2020 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced that the Company will release results for its second quarter of 2020 ended June 30, 2020, after the market closes on Thursday, August 6th, 2020, and will hold a conference ca...
RANCHO CUCAMONGA, Calif., June 12, 2020 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced today that Bill Peters, CFO, Dan Dischner, Vice President of Corporate Communications and Human Resources, and Tony Marrs, Sr. Vice President Regulatory Affairs and Clinical ...
A coalition of 51 attorneys general in the U.S. has filed an antitrust complaint in federal court against 26 companies making generic dermatology drugs and 10 executives at these firms claiming wide-spread price-fixing, marketing allocating and bid-rigging related to over 80 different...
The FDA has approved Amphastar Pharmaceuticals' (NASDAQ: AMPH ) Abbreviated New Drug Application for Succinylcholine Chloride Injection USP, 200 mg/10 mL (20 mg/mL) Multiple-Dose Vial, a therapeutic equivalent of Pfizer's Quelicin. More news on: Amphastar Pharmaceuticals, ...
RANCHO CUCAMONGA, Calif., June 09, 2020 (GLOBE NEWSWIRE) -- Amphastar ® Pharmaceuticals, Inc., (NASDAQ: AMPH) (“Amphastar”), today announces that the U.S. Food and Drug Administration (“FDA”) has approved its Abbreviated New Drug Application (“ANDA...
RANCHO CUCAMONGA, Calif., June 02, 2020 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced today that Bill Peters, CFO and Dan Dischner, Vice President of Corporate Communications and Human Resources will be presenting at the Jefferies Virtual Healthcare Conference...
Amphastar Pharmaceuticals, Inc. (AMPH) Q1 2020 Earnings Conference Call May 07, 2020, 05:00 PM ET Company Participants Dan Dischner - VP of Corporate Communications Tony Marrs - VP of Clinical Research William Peters - CFO, Treasurer & Senior VP of Finance Conference Call ...
News, Short Squeeze, Breakout and More Instantly...
Amphastar Pharmaceuticals Inc. Company Name:
AMPH Stock Symbol:
NASDAQ Market:
Amphastar Pharmaceuticals Inc. Website:
A look at the top 10 most actives in the United States Complete Solaria Inc Com (CSLR) rose 58.5% to $1.775 on volume of 71,457,263 shares Senti Biosciences Inc. (SNTI) rose 55.1% to $0.428 on volume of 64,207,396 shares Golden Heaven Group Holdings Ltd. (GDHG) rose 13.3% to $0.1711 on vo...
2024-06-19 18:28:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...